Letter to the editor RE: Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'
EBioMedicine
.
2022 Mar:77:103898.
doi: 10.1016/j.ebiom.2022.103898.
Epub 2022 Feb 24.
Authors
Douglas F Lake
1
,
Alexa J Roeder
2
,
Alim Seit-Nebi
3
,
Maria J Gonzalez-Moa
3
,
Sergei Svarovsky
3
Affiliations
1
School of Life Sciences, Arizona State University, Tempe AZ, United States. Electronic address: douglas.lake@asu.edu.
2
School of Life Sciences, Arizona State University, Tempe AZ, United States.
3
Axim Biotechnologies, San Diego, CA, United States.
PMID:
35220041
PMCID:
PMC8866046
DOI:
10.1016/j.ebiom.2022.103898
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Neutralizing* / immunology
Antibodies, Viral
COVID-19*
Humans
Point-of-Care Systems
SARS-CoV-2
Substances
Antibodies, Neutralizing
Antibodies, Viral